Rhizen Pharmaceuticals AG Details: 580 Social Audience

Rhizen Pharmaceuticals AG Overview

Headquarters: Basel, Basel-stadt, Ch
Website: www.rhizen.com
Industry: Research Services
Employees: 126
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

Developing The Next Generation Medicines That Will Lead The Fight Against Cancer

About Rhizen Pharmaceuticals AG

Rhizen is Swiss HQ biotech focused on discovery and development of innovative, small molecule drugs for the treatment of cancer & inflammatory diseases. We have demonstrated our leadership of the PI3K space through our discovery of Umbralisib & Tenalisib - class leading PI3K isoform-specific inhibitors that are poised to transform the NHL & CLL space. We have a deep pipeline of novel differentiated assets across various stages of development.